A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China

Condition:   Tuberculosis, Multidrug-Resistant Interventions:   Drug: Bedaquiline;   Drug: Levofloxacin;   Drug: Linezolid;   Drug: Cycloserine;   Drug: Clofazimine;   Drug: Pyrazinamide;   Drug: Protionamide Sponsor:   Beijing Chest Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials